3:53 PM
 | 
Nov 03, 2017
 |  BC Extra  |  Company News

Management tracks: Tissue Regenix, Therapix

Regenerative medical device company Tissue Regenix Group plc (LSE:TRX) named Steve Couldwell CEO. A Tissue Regenix director since 2013, Couldwell was COO of global biosurgery at Sanofi (Euronext:SAN; NYSE:SNY).

Cannabinoid company Therapix Biosciences Ltd. (Tel Aviv:TRPX; NASDAQ:TRPX) named its chairman, Ascher Shmulewitz, interim CEO. Elran Haber stepped down as CEO in May.

Epigenetics company Cambridge Epigenetix Ltd. (Babraham, U.K.) hired Hayden Jeffreys as COO....

Read the full 299 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >